MedTrace Logo

A Study of MI078 for Postpartum Depression

NCT07721961 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2026-07-23

No results posted yet for this study

Summary

This is a multicenter, randomized, double-blind, placebo-controlled trial consisting of an experimental drug group and a placebo group, each enrolling 100 participants. The objective of this study is to assess the efficacy and safety of MI078 capsules for the treatment of postpartum depression.

Conditions

  • Postpartum Depression (PPD)

Interventions

DRUG

MI078 capsule

MI078 capsule for 3 days

DRUG

Placebo of MI078 capsules

Placebo for 3days

Sponsors & Collaborators

  • Nanjing Minova Pharmaceutical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • gang Wang · Beijing Anding Hospital, Capital Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-10
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07721961 on ClinicalTrials.gov